03.12.2021 · Blueprint Medicines' (BPMC) Ayvakit, which has been approved to treat PDGFRA Exon 18 mutant gastrointestinal stromal tumors, has seen strong uptake since approval. However, stiff competition ...
07.12.2021 · Blueprint Medicines' (NASDAQ:BPMC) Compensation Committee board granted non-qualified stock options to purchase 39,862 shares and 19,930 restricted stock units (RSU) to 13 new employees under ...
Find the latest Blueprint Medicines Corporation (BPMC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock ...
03.12.2021 · Find the latest BLUEPRINT MEDICINES CORP BLUEPR (0HOJ.L) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
09.12.2021 · CAMBRIDGE, Mass., Dec. 9, 2021 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of Daniella Beckman to its board of directors. Ms. Beckman, who is currently the Chief Financial Officer of Tango Therapeutics and board member for Vor Biopharma and 5:01 Acquisition Corp, brings more than 20 years of corporate strategy, …
Find the latest Blueprint Medicines Corporation (BPMC) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
24.11.2021 · A high-level overview of Blueprint Medicines Corporation (BPMC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.